Supriya Lifescience Limited — Others, 01-02-2025: Cessation

Mr. Kedar Karmarkar and Mr. Bhairav Chokshi have retired as Independent Directors of Supriya Lifescience upon completing their two terms of five years on February 1, 2025. In their stead, Dr. Ganapati Dadasaheb Yadav and Dr. Sunil Subhash Bhagwat have been appointed as Additional Directors in the Non-Executive, Independent category. This leadership transition may enhance governance and introduce new perspectives beneficial to the company. Investors might view this shift positively, seeing potential for strategic renewal, though continued monitoring of board dynamics will be essential.